The Neogen® Molecular Detection System (MDS) provides an all-in-one solution for pathogen screening, saving laboratories time and cost while ensuring accurate and reliable results. With easy-to-use reagents, one protocol for all pathogens and same-day or next-day results, the MDS enables laboratories to make critical decisions quickly and release products safely.
The MDS helps improve productivity and protect consumers and businesses through its ability to test multiple types of pathogens simultaneously. The innovative technology behind the system is constantly evolving to meet changing market needs, and the assays can detect up to 1-5 CFU of target material even in the most challenging sample matrices.
With ready-to-use reagents, simple process control and streamlined workflows, the MDS provides a reliable and efficient pathogen screening solution. In addition, the compact and low-maintenance Neogen® Molecular Detection Instrument (MDS) maximizes laboratory output with its large capacity and flexibility.
The powerful and intuitive Neogen® Molecular Detection Software provides fast results and a user-friendly interface, allowing laboratories to make quick decisions on important issues that can affect public health and business performance.
With available Molecular Detection Assays for a wide range of pathogens, such as Campylobacter, Cronobacter, E. coli O157, Listeria monocytogenes, Salmonella and more, the MDS provides a comprehensive solution for pathogen screening in laboratories.
